✦ LIBER ✦

Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer

✍ Scribed by Junichi Kurebayashi; Sumiko Okubo; Yutaka Yamamoto; Hiroshi Sonoo

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 363 KB
Volume: 11
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02968000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of estrogen signaling activat

Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer

✍ Yuan Yao; Angela M. H. Brodie; Nancy E. Davidson; Thomas W. Kensler; Qun Zhou 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 399 KB

Novel actions of tyrphostin AG 879: inhi

Novel actions of tyrphostin AG 879: inhibition of RAF-1 and HER-2 expression combined with strong antitumoral effects on breast cancer cells

✍ L. -I. Larsson 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 266 KB

Elesclomol, counteracted by Akt survival

Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells

✍ Ying Qu; Jinhua Wang; Myung-Shin Sim; Bingya Liu; Armando Giuliano; James Barsou 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 534 KB

Seliciclib (CYC202, R-roscovitine) enhan

Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model

✍ Maria Virginia C.L. Appleyard; Mary A. O'Neill; Karen E. Murray; Fiona E.M. Paul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 503 KB

## Abstract We sought to determine whether seliciclib (CYC202, R‐roscovitine) could increase the antitumor effects of doxorubicin, with no increase in toxicity, in an MCF7 breast cancer xenograft model. The efficacy of seliciclib combined with doxorubicin was compared with single agent doxorubicin

Sodium phenylacetate inhibits the Ras/MA

Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells

✍ Manabu Watanabe; Nozomi Miyajima; Maki Igarashi; Yoshifumi Endo; Natsuko Watanab 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 526 KB

The effect of endocrine therapy with med

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

✍ M. J. Reed; A. Christodoulides; R. Koistinen; M. Seppälä; J. D. Teale; M. W. Ghi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 413 KB 👁 2 views